Kallik Announces Global
Contract Win with Medical
Device Supplier Coloplast
Centralised, end-to-end artwork and content management capabilities of
Kallik AMS360 will vastly reduce labelling & packaging change management
cycles and keep the company in regulatory compliance for the first time
Coloplast, headquartered in Humlebaek, Denmark,
supplies specialist medical therapy products across
the world, with products in three main categories:
urology; ostomy; and wound and skin care. Its
customers are hospitals, institutions, wholesalers
and retailers. The company, which employs over
7,000 people, has production facilities in Denmark,
Hungary, France, China and the US, in addition
to international custom manufacturing
facilities.
“Our processes
have been largely
manual until now.
All of our labelling and
packaging content has
been stored as artwork
files, so every change
has meant starting from
scratch and could take
months to implement,
requiring approvals
of local translations
from 30-40 countries,
incurring ongoing risk.”
Jette Byg, Coloplast’s
Head of Labelling
& Packaging
The aim is that the Kallik AMS360
solution will connect all of these
production facilities, following the
project roll out scheduled for early next year.
Built on a powerful phrase
management and asset repository
foundation, AMS360 is a
comprehensive end-to-end artwork
management system. It provides full
control of approved legal and
regulatory labelling information,
while managing all localised and
translated texts for every target
sales region. A fully visible,
manageable process means
Coloplast will be able to maintain
consistent, branded artwork and
imagery across its multiple product
ranges.
Explaining the company’s reasons for choosing
Kallik, Jette Byg, Coloplast’s Head of Labelling
& Packaging, says, “We were about to upgrade
our internal systems when we saw Kallik at
an exhibition, bringing a completely different
perspective to the way we could manage our
content management activities.”
“Our processes have been largely manual until
now. All of our labelling and packaging content
has been stored as artwork files, so every change
has meant starting from scratch and could take
months to implement, requiring approvals of local
translations from 30-40 countries, incurring ongoing
risk.”
“Kallik centralises everything and uses a database
to store approved content, which only needs to be
amended in one place. We will be able to re-use
approved sentences, so we won’t have to get each
change approved in every territory. The impact of
this will be huge.”
Coloplast estimates that, as a result of using the
Kallik AMS solution, it will be able to reduce its
labelling and packaging resources due to much
shorter change management cycles. It will minimise
instances of wrong labels being printed, and
product recalls. Ensuring products go out with
correct, readable labels will enhance its image as
a company too.
For more information visit www.kallik.com
or telephone: +44 (0) 1827 318100